Recombinant Human GDF-15

Recombinant Human GDF-15 (Growth Differentiation Factor 15) is a multifunctional cytokine with key roles in metabolism, immune regulation, and disease modeling, making it a valuable tool for diverse research applications.

Key scientific reasons to use recombinant human GDF-15:

• Metabolic Regulation: GDF-15 modulates appetite, energy expenditure, and body weight. Administration of recombinant GDF-15 in animal models consistently reduces food intake and body weight, improves glucose tolerance, enhances insulin sensitivity, and promotes fatty acid oxidation. This makes it highly relevant for studies on obesity, diabetes, and metabolic syndrome.

• Immune Modulation: GDF-15 acts as an immune checkpoint, regulating immune tolerance and inflammation. Recombinant GDF-15 has been shown to reduce inflammatory markers and promote anti-inflammatory macrophage phenotypes in adipose tissue, which is crucial for research on chronic inflammation, sepsis, and immune-related diseases.

• Cancer Biology: GDF-15 is implicated in tumor suppression and cancer immunotherapy. It influences cell survival, immune evasion, and cachexia, and recombinant GDF-15 is used to model these effects in vitro and in vivo.

• Cardiovascular and Tissue Protection: GDF-15 functions as a protective factor in cardiovascular disease models, reducing hypertrophy and tissue damage. Recombinant protein enables mechanistic studies and therapeutic exploration in cardiac research.

• Cell Signaling and Mechanistic Studies: Recombinant GDF-15 activates specific signaling pathways (e.g., SMAD2/3 phosphorylation via TGF-β receptors), allowing detailed investigation of downstream effects in cell culture and animal models.

• Experimental Consistency: Using recombinant human GDF-15 ensures controlled dosing, reproducibility, and species specificity in experimental setups, which is critical for mechanistic studies and translational research.

Best practices and considerations:

• Purity and Activity: Ensure the recombinant protein is free from contaminants (e.g., TGF-β), as impurities can confound results, especially in signaling assays.
• Species Compatibility: Use human GDF-15 for human cell studies and cross-species experiments; confirm activity in your model system.
• Storage and Handling: Recombinant GDF-15 is typically supplied lyophilized and should be reconstituted and stored according to manufacturer protocols to maintain stability and bioactivity.

Applications include:

• Metabolic disease modeling (obesity, diabetes)
• Cancer biology and immunotherapy research
• Inflammation and immune regulation studies
• Cardiovascular protection and tissue injury models
• Mechanistic cell signaling assays

In summary, recombinant human GDF-15 is a versatile reagent for dissecting its physiological and pathophysiological roles, validating therapeutic targets, and modeling disease mechanisms in preclinical research.

Yes, recombinant human GDF-15 can be used as a standard for quantification or calibration in ELISA assays, provided it is of high purity and its concentration is accurately known. This is a common practice in quantitative ELISA protocols for GDF-15.

Supporting details:

• ELISA kits for GDF-15 are routinely calibrated using recombinant human GDF-15. For example, several commercial ELISA kits specify that their calibration curves are generated using highly purified recombinant human GDF-15, often produced in mammalian (CHO) or bacterial (E. coli) expression systems. These standards are used to generate a dilution series that defines the assay’s quantitative range.

• Assay specificity and parallelism: Validation data from leading kit manufacturers show that the standard curves generated with recombinant GDF-15 are parallel to those obtained with natural (endogenous) GDF-15, indicating that recombinant protein is suitable for quantification.

• Requirements for use as a standard:

  • The recombinant GDF-15 must be of high purity (typically >95% by SDS-PAGE).
  • The protein concentration must be accurately determined (e.g., by absorbance at 280 nm or amino acid analysis).
  • The recombinant protein should match the mature form of GDF-15 recognized by the antibodies in your ELISA (usually the C-terminal mature domain, not the pro-form).
  • The buffer composition should be compatible with the ELISA diluent to avoid matrix effects.

• Best practices:

  • Prepare a serial dilution of the recombinant GDF-15 in the same buffer or matrix as your samples to generate a standard curve.
  • Confirm that the recombinant standard is recognized by the capture and detection antibodies in your specific ELISA system. Most commercial sandwich ELISAs for GDF-15 are validated for both natural and recombinant forms.
  • If using a recombinant standard not supplied with your ELISA kit, validate parallelism by comparing the standard curve to that of the kit’s original standard, if available.

• Limitations: Some recombinant proteins are supplied for use as standards only and are not validated for use in functional bioassays (e.g., cell signaling), and vice versa. Always check the product documentation for intended use.

In summary: As long as your recombinant human GDF-15 is of high purity, accurately quantified, and matches the mature form recognized by your ELISA antibodies, it is appropriate to use it as a standard for quantification or calibration in ELISA assays.

Recombinant Human GDF-15 has been validated for a range of applications in published research, primarily in functional assays, blocking assays, immunoassays (such as ELISA), and as a standard in biochemical and cell-based studies. It is also widely used in in vivo and in vitro functional studies to investigate its biological effects on metabolism, inflammation, cell survival, and disease models.

Key validated applications include:

• Functional Assays:
  Recombinant GDF-15 is used to study its biological activity, such as activation of signaling pathways (e.g., SRE-SEAP reporter assays in HEK293 cells transfected with GFRAL and RET), induction of Smad2/3 phosphorylation, and modulation of cellular responses (e.g., appetite suppression, neuronal survival, β-cell protection).

• Blocking Assays:
  Used to block or neutralize endogenous GDF-15 activity in cell culture or animal models to assess its physiological roles.

• Immunoassays (ELISA, Western Blot):
  Recombinant GDF-15 serves as a standard or positive control in ELISA and Western blot assays for quantifying GDF-15 levels in biological samples.

• Cell-based Assays:
  Applied to study effects on various cell types, including macrophages (inhibition of TNF-α production), pancreatic β-cells (protection from cytokine-induced apoptosis), and cardiomyocytes (cardioprotective effects).

• In vivo Studies:
  Used in animal models to investigate effects on weight loss, energy expenditure, glycemic control, and disease progression (e.g., obesity, diabetes, cancer cachexia, cardiovascular disease).

• Biomarker and Mechanistic Studies:
  Utilized in research exploring GDF-15 as a biomarker for metabolic, cardiovascular, and inflammatory diseases, as well as in mechanistic studies of its signaling pathways.

Additional details:

• Recombinant GDF-15 has been shown to bind specifically to its receptor GFRAL in functional binding assays.
• It is used in studies of appetite regulation, metabolic disease, cancer biology, and immune modulation.
• It is often validated for purity and activity by SDS-PAGE, HPLC, and cell-based bioassays.

Summary Table of Validated Applications

These applications are supported by both commercial validation and peer-reviewed research, making recombinant human GDF-15 a versatile tool for studying its diverse physiological and pathological roles.

To reconstitute and prepare Recombinant Human GDF-15 protein for cell culture experiments, dissolve the lyophilized protein in an acidic buffer such as sterile 4 mM HCl or sterile water, typically at concentrations ranging from 0.1 mg/mL to 0.3 mg/mL, depending on the specific formulation and experimental requirements. For optimal stability and activity, follow these steps:

1. Centrifuge the vial briefly before opening to ensure all lyophilized material is at the bottom.
2. Add the recommended reconstitution buffer:
   • For carrier-free formulations: Use sterile 4 mM HCl at 100–300 μg/mL.
   • For formulations with carrier protein (e.g., BSA): Use sterile 4 mM HCl containing at least 0.1% human or bovine serum albumin at 100 μg/mL.
   • For some products, sterile water at 0.1 mg/mL is acceptable.
3. Gently pipette to dissolve the protein, washing down the sides of the vial. Do not vortex, as vigorous mixing can denature the protein.
4. Aliquot the solution to avoid repeated freeze-thaw cycles, which can degrade protein activity.
5. Store aliquots at −20°C for short-term or −80°C for long-term use.

Additional notes for cell culture use:

• If the protein is reconstituted in acidic buffer (HCl), dilute it further in cell culture medium or buffer to reach the desired working concentration, ensuring the final pH is compatible with cell viability.
• If required, add a carrier protein (e.g., BSA) to minimize adsorption losses and stabilize the protein, especially at low concentrations.
• Filter sterilize the final working solution if necessary, using a 0.2 μm filter, to ensure sterility for cell culture applications.

Summary Table: Reconstitution Conditions

Always consult the specific product datasheet for precise instructions, as formulations may vary between suppliers. For cell culture, ensure the final solution is compatible with your assay and cell type.